Neuland Laboratories Ltd. - Research Center
524558 NEULANDLAB Group (A) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
| 12.90 |
12.90 |
12.90 |
12.90 |
12.90 |
Share application money
Preference share capital
Reserves & surplus
| 1,504.05 |
1,262.80 |
974.63 |
821.83 |
768.14 |
Secured loans
| 136.01 |
82.51 |
121.51 |
230.95 |
145.12 |
Unsecured loans
Total
| 1,652.96 |
1,358.21 |
1,109.04 |
1,065.68 |
926.16 |
Gross block
| 1,228.68 |
1,080.40 |
962.38 |
926.86 |
837.69 |
Less : revaluation reserve
Less : accumulated depreciation
| 273.79 |
256.74 |
204.84 |
159.50 |
121.86 |
Net block
| 954.05 |
822.81 |
756.70 |
766.52 |
714.99 |
Capital work-in-progress
| 47.66 |
45.89 |
40.57 |
20.46 |
17.25 |
Investments
| 109.37 |
1.44 |
0.68 |
4.03 |
7.05 |
Current assets, loans & advances
| 1,066.25 |
959.95 |
780.55 |
590.27 |
583.39 |
Less : current liabilities & provisions
| 524.37 |
471.88 |
469.46 |
315.60 |
396.52 |
Total net current assets
| 541.88 |
488.06 |
311.09 |
274.67 |
186.86 |
Miscellaneous expenses not written
Total
| 1,652.96 |
1,358.21 |
1,109.04 |
1,065.68 |
926.16 |
Book value of unquoted investments
| 101.69 |
1.44 |
0.41 |
3.78 |
6.86 |
Market value of quoted investments
Contingent liabilities
| 92.22 |
140.47 |
100.72 |
92.99 |
127.52 |
Number of equity sharesoutstanding (Lacs)
| 128.30 |
128.30 |
128.30 |
128.30 |
128.30 |